Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Procter and Gamble
Information provided by:
Alexion Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00088179
First received: July 21, 2004
Last updated: February 15, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 15, 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):